Annual EBIT
-$9.26 M
+$1.18 M+11.32%
December 31, 2023
Summary
- As of February 7, 2025, BDRX annual earnings before interest & taxes is -$9.26 million, with the most recent change of +$1.18 million (+11.32%) on December 31, 2023.
- During the last 3 years, BDRX annual EBIT has risen by +$20.82 million (+69.21%).
- BDRX annual EBIT is now -27.73% below its all-time high of -$7.25 million, reached on December 1, 2013.
Performance
BDRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BDRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.3% | - | - |
| 3 y3 years | +69.2% | - | - |
| 5 y5 years | +41.2% | - | - |
BDRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | +11.3% | ||||
| 5 y | 5-year | -11.1% | +69.2% | ||||
| alltime | all time | -27.7% | +69.2% |
Biodexa Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$9.26 M(-11.3%) | - | - |
| Dec 2022 | -$10.45 M(+25.2%) | - | - |
| Dec 2021 | -$8.34 M(-72.3%) | - | - |
| Dec 2020 | -$30.08 M(+117.6%) | - | - |
| Dec 2019 | -$13.82 M(-12.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$15.76 M(-5.1%) | - | - |
| Dec 2017 | -$16.61 M(+47.4%) | - | - |
| Dec 2016 | -$11.27 M(-34.3%) | - | - |
| Dec 2015 | -$17.16 M(+7.5%) | - | - |
| Dec 2014 | -$15.95 M(+120.0%) | - | - |
| Dec 2013 | -$7.25 M | - | - |
FAQ
- What is Biodexa Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual EBIT year-on-year change?
What is Biodexa Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of BDRX is -$9.26 M
What is the all time high annual EBIT for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.25 M
What is Biodexa Pharmaceuticals annual EBIT year-on-year change?
Over the past year, BDRX annual earnings before interest & taxes has changed by +$1.18 M (+11.32%)